BIOMAT Database Logo BIOMAT Database Logo

Nitric oxide depresses GABAA receptor function via coactivation of cGMP-dependent kinase and phosphodiesterase. 1998

E M Wexler, and P K Stanton, and S Nawy
Department of Ophthalmology and Visual Science, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Nitric oxide (NO) is thought to play an essential role in neuronal processing, but the downstream mechanisms of its action remain unclear. We report here that NO analogs reduce GABA-gated currents in cultured retinal amacrine cells via two distinct, but convergent, cGMP-dependent pathways. Either extracellular application of the NO-mimetic S-nitroso-N-acetyl-penicillamine (SNAP) or intracellular perfusion with cGMP depressed GABA currents. This depression was partially blocked by a pseudosubstrate peptide inhibitor of cGMP-dependent protein kinase (PKG), suggesting both PKG-dependent and independent actions of cGMP. cAMP-dependent protein kinase (PKA) is known to enhance retinal GABA responses. 8-Bromoinosine 3',5'-cyclic monophosphate (8Br-cIMP), which activates a type of cGMP-stimulated phosphodiesterase that hydrolyzes cAMP, also significantly reduced GABA currents. 1-Methyl-3-isobutylxanthine (IBMX), a nonspecific phosphodiesterase (PDE) inhibitor, blocked both the action of 8Br-cIMP and the portion of SNAP-induced depression that was not blocked by PKG inhibition. Our results suggest that NO depresses retinal GABAA receptor function by simultaneously upregulating PKG and downregulating PKA.

UI MeSH Term Description Entries
D007289 Cyclic IMP Inosine cyclic 3',5'-(hydrogen phosphate). An inosine nucleotide which acts as a mild inhibitor of the hydrolysis of cyclic AMP and cyclic GMP and as an inhibitor of cat heart cyclic AMP phosphodiesterase. Inosine Cyclic 3',5'-Monophosphate,Inosine Cyclic Monophosphate,Inosine Cyclic-3',5'-Monophosphate,Cyclic 3',5'-Monophosphate, Inosine,Cyclic Monophosphate, Inosine,Cyclic-3',5'-Monophosphate, Inosine,IMP, Cyclic,Inosine Cyclic 3',5' Monophosphate
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009599 Nitroprusside A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins. Nitroferricyanide,Sodium Nitroprusside,Cyanonitrosylferrate,Ketostix,Naniprus,Nipride,Nipruton,Nitriate,Nitropress,Nitroprussiat Fides,Nitroprusside, Disodium Salt,Nitroprusside, Disodium Salt, Dihydrate,Disodium Salt Nitroprusside,Nitroprusside, Sodium
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D010726 Phosphodiesterase Inhibitors Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterase Antagonists,Phosphodiesterase Inhibitor,Phosphoric Diester Hydrolase Inhibitors,Antiphosphodiesterases,Inhibitor, Phosphodiesterase
D010727 Phosphoric Diester Hydrolases A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. Phosphodiesterase,Phosphodiesterases,Hydrolases, Phosphoric Diester
D011810 Quinoxalines Quinoxaline
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat

Related Publications

E M Wexler, and P K Stanton, and S Nawy
Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons.
June 2010, Synapse (New York, N.Y.),
E M Wexler, and P K Stanton, and S Nawy
Nitric oxide releasing nanofiber stimulates revascularization in response to ischemia via cGMP-dependent protein kinase.
January 2024, PloS one,
E M Wexler, and P K Stanton, and S Nawy
Nitric oxide regulation of gene transcription via soluble guanylate cyclase and type I cGMP-dependent protein kinase.
April 1999, The Journal of biological chemistry,
E M Wexler, and P K Stanton, and S Nawy
Nitric oxide reduces flow-induced superoxide production via cGMP-dependent protein kinase in thick ascending limbs.
May 2009, American journal of physiology. Renal physiology,
E M Wexler, and P K Stanton, and S Nawy
Kinetics of a cellular nitric oxide/cGMP/phosphodiesterase-5 pathway.
June 2004, The Journal of biological chemistry,
E M Wexler, and P K Stanton, and S Nawy
cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.
June 2003, The Biochemical journal,
E M Wexler, and P K Stanton, and S Nawy
cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.
September 2010, Pharmacological reviews,
E M Wexler, and P K Stanton, and S Nawy
Antagonism of the positive dromotropic effect of isoproterenol by adenosine: role of nitric oxide, cGMP-dependent cAMP-phosphodiesterase and protein kinase G.
September 2000, Journal of molecular and cellular cardiology,
E M Wexler, and P K Stanton, and S Nawy
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.
March 2015, Nature,
E M Wexler, and P K Stanton, and S Nawy
The Endothelium-Dependent Nitric Oxide-cGMP Pathway.
January 2016, Advances in pharmacology (San Diego, Calif.),
Copied contents to your clipboard!